Horizon Therapeutics Public Ltd Co Proceeds from Notes Payable
Horizon Therapeutics Public Ltd Co reported Proceeds from Notes Payable of $55.58 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2015-02-27
- Horizon Therapeutics Public Ltd Co proceeds from notes payable for the quarter ending 2012-12-31 was $0.00.
- Horizon Therapeutics Public Ltd Co proceeds from notes payable for the quarter ending 2012-09-30 was $0.00.
- Horizon Therapeutics Public Ltd Co proceeds from notes payable for the quarter ending 2012-06-30 was $0.00.
- Horizon Therapeutics Public Ltd Co proceeds from notes payable for the quarter ending 2012-03-31 was $55.58M.
- Horizon Therapeutics Public Ltd Co proceeds from notes payable for fiscal 2012 was $55.58M, a 233.78% increase from fiscal 2011.
- Horizon Therapeutics Public Ltd Co proceeds from notes payable for fiscal 2011 was $16.65M, a 65.55% increase from fiscal 2010.
- Horizon Therapeutics Public Ltd Co proceeds from notes payable for fiscal 2010 was $10.06M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $0.00 derived: sum of 2 quarters · filed 2015-02-27 | $0.00 derived: sum of 3 quarters · filed 2015-02-27 | $55.58M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $55.58M 10-Q · filed 2013-11-08 | $55.58M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $55.58M 10-Q · filed 2013-08-09 | $55.58M derived: sum of 3 quarters · filed 2014-03-13 | $55.58M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-03-31 | $55.58M 10-Q · filed 2013-05-10 | $55.58M derived: sum of 2 quarters · filed 2014-03-13 | $55.58M derived: sum of 3 quarters · filed 2014-03-13 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $0.00 derived: sum of 2 quarters · filed 2014-03-13 | $16.65M 10-K · filed 2014-03-13 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $16.65M 10-Q · filed 2012-11-13 | |||
| 2011-06-30 | $16.65M 10-Q · filed 2012-08-10 | ||||
| 2010-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $10.06M 10-K · filed 2013-03-18 | $11.96M 10-K · filed 2012-03-23 | ||
| 2010-09-30 | $11.81M 10-Q · filed 2011-11-14 |